A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK

Severe combined immunodeficiency (SCID) can be detected through newborn bloodspot screening. In the UK, the National Screening Committee (NSC) requires screening programmes to be cost-effective at standard UK thresholds. To assess the cost-effectiveness of SCID screening for the NSC, a decision-tree...

Descripción completa

Detalles Bibliográficos
Autores principales: Bessey, Alice, Chilcott, James, Leaviss, Joanna, de la Cruz, Carmen, Wong, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510246/
https://www.ncbi.nlm.nih.gov/pubmed/33072987
http://dx.doi.org/10.3390/ijns5030028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510246/
https://www.ncbi.nlm.nih.gov/pubmed/33072987
http://dx.doi.org/10.3390/ijns5030028

Ejemplares similares